Adoptive Cell Therapies: Keeping Pace With New and Emerging Advances
Presented by Patricia Mangan, RN, MSN, CRNP, and Edward Stadtmauer, MD
From Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania
Presenters’ disclosures of conflicts of interest are found at the end of this article.
J Adv Pract Oncol 2020;11(3):240–244 |
© 2020 Harborside™
At JADPRO Live 2019, Patricia Mangan, RN, MSN, CRNP, and Edward Stadtmauer, MD, discussed the emerging world of chimeric antigen receptor (CAR) T-cell therapy, including the CAR T-cell process, approved indications and studies in hematologic malignancies, strategies for monitoring and managing emerging toxicities, and future directions in the use of this novel therapy.
For access to the full length article, please sign in